Live cell imaging market will reach $3.54 billion by 2027.

CHICAGO, Sep 20, 2022 (GLOBE NEWSWIRE) – According to the latest research report from Arizton, the live cell imaging market is expected to grow at a compound annual growth rate of 8.44% during 2022-2027. The major use of fluorescence microscopy techniques by researchers from pharmaceutical and biotechnology companies, academic institutions, and research centers is increasing the demand for live cell imaging. Artificial intelligence and machine learning in live cell imaging will contribute to the market growth in the coming years.

Scope of the Live Cell Imaging Market Report

Report Attributes details
Market Size (2027) 3.54 billion dollars
Market Size (2021) $2.18 billion
CAGR (2022-2028) 8.44%
base year 2021
prediction year 2022-2027
Market segments Product type, technology type, application type, end user type
Geographical analysis North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Click here to download a free report template

market insights

  • The global live cell imaging market is expected to witness incremental and absolute growth of $1.3 billion and 62.6% respectively during the forecast period.
  • In 2021, the equipment segment captured the highest share (52.10%) of the global live cell imaging market.
  • In 2021, fluorescence microscopy captured the highest share (53.68%) of the global live cell imaging market based on the technology. It is likely to see the highest compound annual growth rate of 8.83% during the forecast period.
  • In 2021, Cell Biology captured the highest share (38.72%) of the global live cell imaging market based on application.
  • Most of the leading market players focus on product launches and approvals, marketing and promotion activities, and research and development investments to enhance their market share and presence.
  • Vendors are also focused on market expansion in existing and new markets to meet the needs of a large customer base, expand their product portfolios, and enhance their production capabilities to attract end users.
  • In 2021, pharmaceutical and biotechnology companies captured the highest share (47.25%) of the global live cell imaging market based on the end user.
  • In 2021, North America captured the highest share (36.35%) of the global live cell imaging market.
  • Global players with well-established infrastructure and research and development support the expansion of their foothold in the market. Consequently, small and emerging sellers may find it increasingly difficult to compete with them in terms of innovation, brand image, technology and pricing.
  • Emerging players in the market must equip AI-enabled microscopes with better accuracy and capacity at competitive prices to sustain themselves in the market.

Deep learning and artificial intelligence enhance live cell imaging techniques

In live cell imaging, the challenge for AI-based methods is not only to detect cells but also to retrieve information from each cell without any human input. AI can greatly simplify the process of data analysis by overcoming these challenges. Low-light imaging and imaging without fluorescent labels are examples of life science microscopy applications where AI-based image analysis holds great promise.

Artificial intelligence or machine learning makes it possible to identify Alzheimer’s patients by interpreting a set of retinal images.

  • Scientists have developed a deep learning model that can identify imaging of vital signs on mammogram screening to predict patients’ breast cancer risk.
  • AI provides feedback to clinicians interacting with patients by pointing to overlooked signals or concerns to improve diagnosis and management.
  • Targeted nanobots are a new drug delivery system.
  • Neural network algorithms can accurately classify gliomas, cervical and breast cancers and identify different stages of cancers.
  • Artificial neural networks, such as AlexNet and GoogLeNet, can accurately distinguish between normal chest X-rays and tuberculosis images after pre-training.

Recent Developments in the Global Live Cell Imaging Market

  • In 2021, CytoSMART Technologies launched the CytoSMART Lux3 BR, a new type of bright field microscope. It is a live cell imaging microscope equipped with a high-quality complementary metal oxide (CMOS) semiconducting camera to aid in label-free cell imaging procedures.
  • In 2021, the Zeiss Group announced the launch of the Zeiss Figner 1, a Zeiss live-cell imaging system and an innovative digital microscope that facilitates comprehensive, real-time focusing through its Micro-Mirror Array System.
  • In 2020, CytoSMART Technologies launched CytoSMART Multi Lux, a live cell remote imaging system.
  • In 2020, Etaluma has partnered with innoME GmbH to offer entry-level brood cell imaging in the Americas.

main sellers

  • Danaher
  • Agilent Technologies
  • Birkin Elmer
  • Merck KGaA
  • Zeiss
  • Thermo Fisher Scientific

Other notable sellers

  • Axion Biosystems
  • BD
  • Bio-Rad Laboratories
  • blu ray biotechnology
  • broker
  • Eppendorf
  • Italuma
  • Grace Bio Labs
  • ibidi GmbH
  • Intelligent imaging innovations
  • Keynes
  • Vital Logo Systems
  • NanoEntek
  • Nanolife SA
  • Nikon
  • Clear
  • ONE
  • oxford machines
  • Phase concentration
  • Three-dimensional imaging stage PHI AB
  • Proteintech . group
  • Sartorius AG
  • Sony biotechnology
  • tomocop

Market segmentation

Product Type

  • equipment
  • consumables
  • Programming


  • fluorescence microscope
  • confocal microscope
  • transmitted light microscope
  • Aharon


  • cell biology
  • real estate discovery
  • developmental biology
  • Stem Cells

end users

  • Pharma and biotechnology companies
  • Academic and research centers
  • Aharon


  • North Amarica
  • Europe
    • Germany
    • France
    • United kingdom
    • Italia
    • Spain
  • your father
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin america
  • Middle East and Africa
    • turkey
    • Kingdom Saudi Arabia
    • South Africa
    • The United Arab Emirates

Explore our Healthcare Life Sciences profile to learn more about the industry.

Click here to download a free report template

Read some of the bestselling reports:

Around ariston:

Arizton Advisory and Intelligence is a company driven by innovation and quality, providing cutting-edge research solutions to clients around the world. We excel in providing comprehensive market intelligence reports, advisory and advisory services.

We provide comprehensive market research reports on industries such as consumer goods, retail technology, automotive, mobility, smart technology, healthcare, life sciences, industrial machinery, chemicals, materials, information technology, media, logistics and packaging. These reports contain a detailed analysis of the industry, market size, share, growth drivers, and trend forecasts.

Arizton is comprised of a team of incoming and experienced analysts who are proficient in creating conclusive reports. Our professional analysts have perfect market research skills. We train our team in advanced research practices, techniques, and ethics to excel in creating robust research reports.

Click here to contact us

Call: +1-312-235-2040
+1 302469 0707


Leave a Comment